1. Metabolic Enzyme/Protease
  2. Phosphodiesterase (PDE)

AN-2728 (Synonyms: Crisaborole)

Cat. No.: HY-10978 Purity: 99.95%
Data Sheet SDS Handling Instructions

AN-2728 is a potent inhibitor of PDE4 and cytokine release; inhibit PDE4 with an IC50 of 0.49 μM.

For research use only. We do not sell to patients.
AN-2728 Chemical Structure

AN-2728 Chemical Structure

CAS No. : 906673-24-3

Size Price Stock Quantity
Free Sample (0.5-1 mg)   Apply now  
10 mM * 1 mL in DMSO $55 In-stock
5 mg $50 In-stock
10 mg $70 In-stock
50 mg $90 In-stock
100 mg $160 In-stock
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

Featured Recommendations

Related Screening Libraries:

  • Biological Activity

  • Protocol

  • Technical Information

  • Purity & Documentation

  • References

Description

AN-2728 is a potent inhibitor of PDE4 and cytokine release; inhibit PDE4 with an IC50 of 0.49 μM.

IC50 & Target

IC50: 0.49 μM (PDE4)[1]

In Vitro

AN-2728 inhibits PDE4, TNF-α, IL-2, IFN-γ, IL-5 and IL-10 with IC50 values of 0.49, 0.54, 0.61, 0.83, 2.4 and 5.3 μM. AN-2728 shows the most potent activity against PDE4 catalytic domain, but it also shows inhibition against PDE1A3, PDE3Cat, and PDE7A1. AN-2728 inhibits PDE isozymes PDE1A3, PDE3Cat , PDE4Cat and PDE7A1 with IC50 values of 6.1, 6.4, 0.11 and 0.73 μM[1]. Crystallography reveals that interaction of benzoxaboroles with the hydrophobic pocket in the PDE4 catalytic domain increase their affinity for PDE4. These benzoxaboroles strongly suppresses the secretion of cytokines associated with Ps and AD[2]. AN-2728 is a topically administered, boron-containing, anti-inflammatory compound that inhibits PDE4 activity and thereby suppresses the release of TNFalpha, IL-12, IL-23 and other cytokines[3].

In Vivo

AN-2728 shows significant inhibition against the ear edema caused by phorbol ester after dosing at 1 mg/ear×2 (78% and 68%, respectively). The efficacy is comparable to that of dexamethasone, suggesting that AN-2728 has good anti-inflammatory activity as well as skin penetration[1]. AN-2728 is reported to be well tolerated and to demonstrate significant effects on markers of efficacy, with results that were comparable to positive controls in clinical trials[3].

Clinical Trial
NCT Number Sponsor Condition Start Date Phase
NCT01652885 Pfizer Dermatitis, Atopic July 2012 Phase 1|Phase 2
NCT01300052 Pfizer Psoriasis January 26, 2011 Phase 2
NCT00759161 Pfizer Psoriasis November 2007 Phase 2
NCT01029405 Pfizer Psoriasis November 2009 Phase 2
NCT01602341 Pfizer Dermatitis, Atopic August 2012 Phase 2
NCT00755196 Pfizer Psoriasis September 2008 Phase 2
NCT02118792 Pfizer Dermatitis, Atopic March 2014 Phase 3
NCT02118766 Pfizer Dermatitis, Atopic March 2014 Phase 3
NCT01258088 Pfizer Plaque-Type Psoriasis November 2010 Phase 1
NCT01301508 Pfizer Dermatitis, Atopic May 2011 Phase 2
NCT00763204 Pfizer Psoriasis February 2008 Phase 1
NCT00762658 Pfizer Psoriasis November 2007 Phase 1
NCT01652885 Pfizer Dermatitis, Atopic July 2012 Phase 1|Phase 2
NCT01300052 Pfizer Psoriasis January 26, 2011 Phase 2
NCT00759161 Pfizer Psoriasis November 2007 Phase 2
NCT01029405 Pfizer Psoriasis November 2009 Phase 2
NCT01602341 Pfizer Dermatitis, Atopic August 2012 Phase 2
NCT00755196 Pfizer Psoriasis September 2008 Phase 2
NCT02118792 Pfizer Dermatitis, Atopic March 2014 Phase 3
NCT02118766 Pfizer Dermatitis, Atopic March 2014 Phase 3
NCT01258088 Pfizer Plaque-Type Psoriasis November 2010 Phase 1
NCT01301508 Pfizer Dermatitis, Atopic May 2011 Phase 2
NCT00763204 Pfizer Psoriasis February 2008 Phase 1
NCT00762658 Pfizer Psoriasis November 2007 Phase 1
View MoreCollapse
References
Molecular Weight

251.05

Formula

C₁₄H₁₀BNO₃

CAS No.

906673-24-3

Storage
Powder -20°C 3 years
  4°C 2 years
In solvent -80°C 6 months
  -20°C 1 month
Shipping

Room temperature in continental US; may vary elsewhere

Solvent & Solubility

DMSO: ≥ 32 mg/mL

* "<1 mg/mL" means slightly soluble or insoluble. "≥" means soluble, but saturation unknown.

Inquiry Online

Your information is safe with us. * Required Fields.

Product name

 

Salutation

Applicant name *

 

Email address *

Phone number

 

Organization name *

Country *

 

Requested quantity *

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
AN-2728
Cat. No.:
HY-10978
Quantity: